Foresee Pharmaceuticals Co., Ltd. announced the change of Senior Vice President of Clinical Development from Yisheng Lee /Chief Medical Officer (Acting Head of Clinical Development) to Bassem Elmankabadi /Senior Vice President, Clinical Development Board Certified Surgeon with 17+ years of clinical background and experience in the pharmaceutical industry including multiple clinical leadership roles at Amgen, Blade Therapeutics and FibroGen. Reason for the change is new appointment. Effective date is April 17, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
95 TWD | -0.11% | +1.50% | -1.25% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-1.25% | 396M | |
+1.51% | 42.75B | |
+49.22% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- 6576 Stock
- News Foresee Pharmaceuticals Co., Ltd.
- Foresee Pharmaceuticals Co., Ltd. Announces Executive Changes